Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Neurology
|
April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H L Pellkofer, M Krumbholz, A Berthele, et al.
Virology
|
March 3, 1997
Growth transformation of antigen-specific T cell lines from rhesus monkeys by herpesvirus saimiri
E Meinl, H Fickenscher, R M Hoch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
J Havla, A Berthele, T Kümpfel, et al.
The Journal of Experimental Medicine
|
August 10, 2000
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe, A Roers, A Waisman, et al.
Neurology
|
December 31, 1997
Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor
R D Voltz, W C Albrich, A Nägele, et al.
Neurology
|
November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
M Clanet, E W Radue, L Kappos, et al.
Brain : a Journal of Neurology
|
May 14, 2008
Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
M Krumbholz, H Faber, F Steinmeyer, et al.
The American Journal of Pathology
|
February 1, 1997
Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques
E MeinL, R M Hoch, K Dornmair, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 6, 1983
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]
H Grosse-Wilde, K V Toyka, U A Besinger, et al.
Journal of Neuroimmunology
|
March 10, 2001
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls
C G Haase, J Guggenmos, U Brehm, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Neurology
|
April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H L Pellkofer, M Krumbholz, A Berthele, et al.
Virology
|
March 3, 1997
Growth transformation of antigen-specific T cell lines from rhesus monkeys by herpesvirus saimiri
E Meinl, H Fickenscher, R M Hoch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
J Havla, A Berthele, T Kümpfel, et al.
The Journal of Experimental Medicine
|
August 10, 2000
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe, A Roers, A Waisman, et al.
Neurology
|
December 31, 1997
Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor
R D Voltz, W C Albrich, A Nägele, et al.
Neurology
|
November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
M Clanet, E W Radue, L Kappos, et al.
Brain : a Journal of Neurology
|
May 14, 2008
Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
M Krumbholz, H Faber, F Steinmeyer, et al.
The American Journal of Pathology
|
February 1, 1997
Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques
E MeinL, R M Hoch, K Dornmair, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 6, 1983
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]
H Grosse-Wilde, K V Toyka, U A Besinger, et al.
Journal of Neuroimmunology
|
March 10, 2001
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls
C G Haase, J Guggenmos, U Brehm, et al.
Page
of 21